What is the ROCE (Return on Capital Employed) of PharmaResearch Co this year?
The ROCE of PharmaResearch Co is 0.21 undefined this year.
PharmaResearch Co ROCE 2024
PharmaResearch Co ROCE
0.21
Ticker
214450.KQ
ISIN
KR7214450009
In 2024, PharmaResearch Co's return on capital employed (ROCE) was 0.21, a 11.01% increase from the 0.19 ROCE in the previous year.
PharmaResearch Co Aktienanalyse
What does PharmaResearch Co do?
PharmaResearch Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling PharmaResearch Co's Return on Capital Employed (ROCE)
PharmaResearch Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing PharmaResearch Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
PharmaResearch Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in PharmaResearch Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about PharmaResearch Co Stock
How has the ROCE (Return on Capital Employed) of PharmaResearch Co developed compared to the previous year?
The ROCE of PharmaResearch Co has increased by 11.01% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of PharmaResearch Co?
A high Return on Capital Employed (ROCE) indicates that PharmaResearch Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of PharmaResearch Co?
A low ROCE (Return on Capital Employed) can indicate that PharmaResearch Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from PharmaResearch Co impact the company?
An increase in the ROCE of PharmaResearch Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of PharmaResearch Co affect the company?
A decrease in ROCE of PharmaResearch Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of PharmaResearch Co?
Some factors that can affect PharmaResearch Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of PharmaResearch Co so important for investors?
The ROCE of PharmaResearch Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can PharmaResearch Co take to improve the ROCE?
To improve the ROCE, PharmaResearch Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does PharmaResearch Co pay?
Over the past 12 months, PharmaResearch Co paid a dividend of 950 KRW . This corresponds to a dividend yield of about 0.66 %. For the coming 12 months, PharmaResearch Co is expected to pay a dividend of 1,044.52 KRW.
What is the dividend yield of PharmaResearch Co?
The current dividend yield of PharmaResearch Co is 0.66 %.
When does PharmaResearch Co pay dividends?
PharmaResearch Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of PharmaResearch Co?
PharmaResearch Co paid dividends every year for the past 12 years.
What is the dividend of PharmaResearch Co?
For the upcoming 12 months, dividends amounting to 1,044.52 KRW are expected. This corresponds to a dividend yield of 0.73 %.
In which sector is PharmaResearch Co located?
PharmaResearch Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von PharmaResearch Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PharmaResearch Co from 4/18/2024 amounting to 950 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
When did PharmaResearch Co pay the last dividend?
The last dividend was paid out on 4/18/2024.
What was the dividend of PharmaResearch Co in the year 2023?
In the year 2023, PharmaResearch Co distributed 660 KRW as dividends.
In which currency does PharmaResearch Co pay out the dividend?
The dividends of PharmaResearch Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PharmaResearch Co
Our stock analysis for PharmaResearch Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaResearch Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- PharmaResearch Co Revenue
- PharmaResearch Co Net Income
- PharmaResearch Co P/E
- PharmaResearch Co P/S
- PharmaResearch Co EBIT
- PharmaResearch Co Dividend
- PharmaResearch Co Stocks
- PharmaResearch Co Market capitalization
- PharmaResearch Co Debt
- PharmaResearch Co Liabilities
- PharmaResearch Co Equity
- PharmaResearch Co AAQS
- PharmaResearch Co Employees
- PharmaResearch Co ROE
- PharmaResearch Co ROA
- PharmaResearch Co ROCE